The European Medicines Agency noted production limitations for the drug Creon.
1 report, 1 independent
Updated Jun 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The European Medicines Agency noted production limitations for the drug Creon.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Reports indicate Europe-wide drug shortages are occurring due to production limitations and high demand, monitored by the European Medicines Agency.Also in this story
- Bidafarma reported supply issues in Malaga, Spain on October 15, 2026.
- A drug shortage in the Czech Republic has forced the use of an emergency EU allowance.
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
- Creon